Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Polyclonal Antibodies in SPK Transplant
NCT03470961Phase 4Unknown
- Sponsor
- Tianjin First Central Hospital
- Start
- Mar 2018
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin rabbit in Simultaneous Pancreas Kidney Transplantation (SPK), sponsored by Tianjin First Central Hospital. Status: unknown.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
Simultaneous Pancreas Kidney Transplantation (SPK)
Beyond the preview
Go deeper on NCT03470961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03470961.